Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition.
Canna SW, Girard C, Malle L, de Jesus A, Romberg N, Kelsen J, Surrey LF, Russo P, Sleight A, Schiffrin E, Gabay C, Goldbach-Mansky R, Behrens EM. Canna SW, et al. Among authors: sleight a. J Allergy Clin Immunol. 2017 May;139(5):1698-1701. doi: 10.1016/j.jaci.2016.10.022. Epub 2016 Nov 19. J Allergy Clin Immunol. 2017. PMID: 27876626 Free PMC article.
Reply.
Canna SW, Girard C, Malle L, de Jesus A, Romberg N, Kelsen J, Surrey LF, Russo P, Sleight A, Schiffrin E, Gabay C, Goldbach-Mansky R, Behrens EM. Canna SW, et al. Among authors: sleight a. J Allergy Clin Immunol. 2017 Jul;140(1):316-317. doi: 10.1016/j.jaci.2017.03.016. Epub 2017 Apr 29. J Allergy Clin Immunol. 2017. PMID: 28460789 No abstract available.
IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome.
Yasin S, Solomon K, Canna SW, Girard-Guyonvarc'h C, Gabay C, Schiffrin E, Sleight A, Grom AA, Schulert GS. Yasin S, et al. Among authors: sleight a. Rheumatology (Oxford). 2020 Feb 1;59(2):442-445. doi: 10.1093/rheumatology/kez284. Rheumatology (Oxford). 2020. PMID: 31359055 Free PMC article. No abstract available.
Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease.
Gabay C, Fautrel B, Rech J, Spertini F, Feist E, Kötter I, Hachulla E, Morel J, Schaeverbeke T, Hamidou MA, Martin T, Hellmich B, Lamprecht P, Schulze-Koops H, Courvoisier DS, Sleight A, Schiffrin EJ. Gabay C, et al. Among authors: sleight a. Ann Rheum Dis. 2018 Jun;77(6):840-847. doi: 10.1136/annrheumdis-2017-212608. Epub 2018 Feb 22. Ann Rheum Dis. 2018. PMID: 29472362 Free PMC article. Clinical Trial.
Trajectories and risk factors of fatigue following colorectal cancer diagnosis.
Li X, Hoogland AI, Small BJ, Crowder SL, Gonzalez BD, Oswald LB, Sleight AG, Nguyen N, Lorona NC, Damerell V, Komrokji KR, Mooney K, Playdon MC, Ulrich CM, Li CI, Shibata D, Toriola AT, Ose J, Peoples AR, Siegel EM, Bower JE, Schneider M, Gigic B, Figueiredo JC, Jim HSL. Li X, et al. Among authors: sleight ag. Colorectal Dis. 2023 Oct;25(10):2054-2063. doi: 10.1111/codi.16746. Epub 2023 Sep 12. Colorectal Dis. 2023. PMID: 37700526
Reporting Rigor of Cancer Rehabilitation Interventions: Application of the CReDECI-2 Guidelines.
Brick R, Voss L, Arbid S, Joshi Y, Ammendolia Tomé G, El Hassanieh D, Sleight AG, Klein C, Sabir A, Wechsler S, Campbell G, Campbell KL, Lam A, Lyons KD, Padgett L, Jones JM. Brick R, et al. Among authors: sleight ag. Am J Phys Med Rehabil. 2023 Nov 1;102(11):1029-1033. doi: 10.1097/PHM.0000000000002324. Epub 2023 Aug 18. Am J Phys Med Rehabil. 2023. PMID: 37594223
Fatigue as an Understudied Barrier to Participation in Life Roles.
Poole JL, Murphy SL, Foster ER, Sleight AG, Van Denend T, Asher A, Carandang K, Finlayson M, Fogelberg D, Jim HSL, Ledingham A, Packer T, Plow M, Preissner K, Wechsler S, Whibley D. Poole JL, et al. Among authors: sleight ag. OTJR (Thorofare N J). 2023 Oct;43(4):583-591. doi: 10.1177/15394492231180833. Epub 2023 Jun 24. OTJR (Thorofare N J). 2023. PMID: 37354021
123 results